Published: Guidance, quality standards and advice

Showing 71 to 80 of 86

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Ramucirumab for previously treated locally advanced or metastatic non-small-cell lung cancer	TA403	24 August 2016	24 August 2016
Ceritinib for previously treated anaplastic lymphoma kinase positive non-small-cell lung cancer	TA395	22 June 2016	22 June 2016
Erlotinib and gefitinib for treating non-small-cell lung cancer that has progressed after prior chemotherapy	TA374	16 December 2015	16 December 2015
Paclitaxel as albumin-bound nanoparticles with carboplatin for untreated non-small-cell lung cancer (terminated appraisal)	TA362	28 October 2015	28 October 2015
Nintedanib for previously treated locally advanced, metastatic, or locally recurrent non‑small‑cell lung cancer	TA347	22 July 2015	22 July 2015
Afatinib for treating epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancer	TA310	23 April 2014	23 April 2014
EGFR‑TK mutation testing in adults with locally advanced or metastatic non-small-cell lung cancer	HTG316	14 August 2013	14 August 2013
Irreversible electroporation for treating primary lung cancer and metastases in the lung	HTG302	23 February 2013	23 February 2013
Erlotinib for the first-line treatment of locally advanced or metastatic EGFR-TK mutation-positive non-small-cell lung cancer	TA258	27 June 2012	27 June 2012
Erlotinib monotherapy for maintenance treatment of non-small-cell lung cancer	TA227	29 June 2011	29 June 2011